Use of a Nutritional Supplement to Treat Diabetic Symptoms in HIV-Infected Adults

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Insulin Resistance, HIV Infections

In brief

The purpose of this study is to determine the effectiveness of the nutritional supplement chromium picolinate in improving insulin resistance, a symptom of diabetes, in HIV-infected patients. The ultimate goal is to find a simple therapy that can prevent the development of diabetes in individuals with HIV.

Key facts

Study ID

NCT00109746

Run by

National Center for Complementary and Integrative Health (NCCIH)

People needed

39

Starts

2005-11-01

Expected to finish

2010-06-01

Last updated by the study team

2016-03-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV infected
• Currently taking an anti-HIV drug regimen
• Insulin Resistant:fasting glucose between 5.56 and 7mmol/L and/or two hour post-glucose load between 7.78 and 11.11mmol/L

You may not qualify if…

• Cancer
• Acute illness that would interfere with the study
• Hypogonadism
• Hypothyroidism
• Untreated hypertension
• CD4 count less than 300 cells/mm3
• Viral load greater than 35,000 copies/ml
• Untreated hepatitis C virus infection
• Pregnancy
• Diabetes

Where it is running

• State University of New York/General Clinical Research Center — Stony Brook, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.